Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer

Laura W Goff; Nilofer S Azad; Stacey Stein; Jennifer G Whisenant; Tatsuki Koyama; Ulka Vaishampayan; Howard Hochster; Roisin Connolly; Amy Weise; Patricia M LoRusso; Safia N Salaria; Wael El-Rifai; Jordan D Berlin

doi:10.1007/s10637-018-0679-5

Back

Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer

Journal article

Peer reviewed

Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer

Laura W Goff, Nilofer S Azad, Stacey Stein, Jennifer G Whisenant, Tatsuki Koyama, Ulka Vaishampayan, Howard Hochster, Roisin Connolly, Amy Weise, Patricia M LoRusso, …

Investigational new drugs, Vol.36(6), pp.1158-1158

2018-12

DOI: https://doi.org/10.1007/s10637-018-0679-5

PMID: 30334109

Abstract

The authors would like to note that the investigator affiliations have been corrected to reflect the actual affiliations of each author. The authors would also like to note an amendment to the first name of the second author. Nilo Azad was changed to reflect the full name of the author, which is Nilofer S. Azad as shown above. The original article has been corrected.

Metrics

6 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.96 Cell Biology; 1.96.311 Microtubules
Web Of Science research areas: Oncology; Pharmacology & Pharmacy
ESI research areas: Pharmacology & Toxicology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer
Creators: Laura W Goff - Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. laura.goff@vumc.org
Nilofer S Azad - Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA
Stacey Stein - Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA
Jennifer G Whisenant - Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
Tatsuki Koyama - Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA
Ulka Vaishampayan - Karmanos Cancer Institute, Detroit, MI, USA
Howard Hochster - Rutgers Canter Institute, New Brunswick, NJ, USA
Roisin Connolly - Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA
Amy Weise - Karmanos Cancer Institute, Detroit, MI, USA
Patricia M LoRusso - Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA
Safia N Salaria - Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Vanderbilt University, 2220 Pierce Avenue, PRB 777, Nashville, TN, 37232, USA
Wael El-Rifai - University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA
Jordan D Berlin - Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
Publication Details: Investigational new drugs, Vol.36(6), pp.1158-1158
Grant note: UM1 CA186689 / NCI NIH HHS
Academic Unit: Miller School of Medicine; UMMG Department of Surgery; UMMG Dept of Surgery - Div of Surgical Oncology
Language: English
Resource Type: Journal article
PMID: 30334109
Record Identifier: 991031615429902976